aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis

Fan, R; Papatheodoridis, G; Sun, J; Innes, H; Toyoda, H; Xie, Q; Mo, SY; Sypsa, V; Guha, IN; Kumada, T; Niu, JQ; Dalekos, G; Yasuda, S; Barnes, E; Lian, JQ; Suri, V; Idilman, R; Barclay, ST; Dou, XG; Berg, T; Hayes, PC; Flaherty, JF; Zhou, YP; Zhang, ZG; Buti, M; Hutchinson, SJ; Guo, YB; Calleja, JL; Lin, LJ; Zhao, LF; Chen, YP; Janssen, HLA; Zhu, CN; Shi, L; Tang, XP; Gaggar, A; Wei, L; Jia, JD; Irving, WL; Johnson, PJ; Lampertico, P; Hou, JL

Johnson, PJ (corresponding author), Univ Liverpool, Dept Mol & Clin Canc Med, 2nd Floor Sherrington Bldg,Ashton St, Liverpool L69 3GE, Merseyside, England.; Hou, JL (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Peoples R China.; Lampertico, P (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, CRC AM & A Migliavacca Ctr Liver Dis, Div Gastroenterol & Hepatol, Milan, Italy.

JOURNAL OF HEPATOLOGY, 2020; 73 (6): 1368